Scott Andrew Smith Net Worth - Insider Trades and Bio as of Jun 20, 2026

VTRSViatris IncSEC CIK: 0001614975

Estimated Net Worth

$38.6 Million

Last Updated: May 19, 2026 11:41 PM EST

Transaction Summary

Total Transactions94

Buy-Sell Ratio0.60

Buy Transactions3

Sell Transactions5

Transaction Volume

Total Volume-$760.74K

Net Volume$2.37M

Buy Volume$805.08K

Sell Volume-$1.57M

Trade Analysis

AVG Trade Size-$168.79K

Largest Trade$536.26K

Most Active MonthDec

Most Active Year2022

Trading Sentiment

OverallBullish

Recent TradeNeutral

Last 90 Days0 Trades

ConvictionNone

Net Worth & Trading Activity Over Time

Monthly Trading Pattern

Past Insider Trading and Trends

Scott Andrew Smith has an estimated net worth of $38.6 Million. This is based on reported shares across multiple companies, which include BioAtla, Inc., Spring Bank Pharmaceuticals, Inc., Viatris Inc, Apexigen, Inc., TITAN PHARMACEUTICALS INC, and CELGENE CORP /DE/.

2015 was Scott Andrew Smith's most active year for acquiring shares with 9 total transactions. Scott Andrew Smith's most active month to acquire stocks was the month of February. 2021 was Scott Andrew Smith's most active year for disposing of shares, totalling 19 transactions. Scott Andrew Smith's most active month to dispose stocks was the month of February. 2025 saw Scott Andrew Smith paying a total of $756,002.40 for 722,186 shares, this is the most they've acquired in one year. In 2026 Scott Andrew Smith cashed out on 2,330,977.272 shares for a total of $9,756,330.12, their largest year based on trade value.

Holdings & Transactions

VTRSviatris inc

Chief Executive Officer

Updated: Mar 10, 2026VIEW QUOTE

Form Type	Δ Own, %	Traded Shares	Price	Size, $	Filing Date	Own, %	Type	Scheduled	Trade Dates	SEC Filing
From 4	0.12	204.64K	$14.16	-$728.28K	Mar 10, 2026	1.85M	Options	—	Mar 06	View
From 4	0.39	680.05K	$14.88	-$9.03M	Mar 05, 2026	2.64M	Options	—	Mar 03 - 04	View
From 4	0.08	22.00K	$9.99	$219.74K	Aug 13, 2025	314.81K	Purchase	—	Aug 12	View
From 4	0.26	60.00K	$8.94	$536.26K	May 14, 2025	292.81K	Purchase	—	May 12	View
From 4	—	373.56K	—	—	Mar 10, 2025	373.56K	Grant	—	Mar 06	View
From 4	-0.14	95.67K	$9.35	-$894.16K	Mar 05, 2025	572.37K	Options	—	Mar 03 - 04	View
From 4	0.53	222.13K	$12.59	-$697.20K	Mar 05, 2024	644.31K	Options	—	Mar 03 - 04	View
From 4	—	407.49K	—	—	Apr 04, 2023	407.49K	Grant	—	Apr 01	View
From 3	—	—	—	—	Dec 29, 2022	—	—	—	—	View

BCABbioatla, inc.

Updated: Jun 18, 2025VIEW QUOTE

Form Type	Δ Own, %	Traded Shares	Price	Size, $	Filing Date	Own, %	Type	Scheduled	Trade Dates	SEC Filing
From 4	0.08	23.50K	—	—	Jun 18, 2025	321.55K	Grant	—	Jun 18	View
From 4	-0.01	2.18K	$1.77	-$3.86K	Sep 03, 2024	298.05K	Tax	—	Aug 31	View
From 4	-0.01	2.18K	$1.81	-$3.95K	Aug 01, 2024	300.23K	Tax	—	Jul 31	View
From 4	-0.01	2.18K	$1.37	-$2.99K	Jul 01, 2024	302.41K	Tax	—	Jun 30	View
From 4	0.06	16.50K	—	—	Jun 14, 2024	304.59K	Grant	—	Jun 13	View
From 4	-0.01	2.18K	$1.51	-$3.29K	May 31, 2024	288.09K	Tax	—	May 31	View
From 4	-0.01	2.18K	$2.26	-$4.93K	May 01, 2024	290.27K	Tax	—	Apr 30	View
From 4	-0.01	2.18K	$3.44	-$7.50K	Apr 01, 2024	292.46K	Tax	—	Mar 31	View
From 4	-0.01	2.18K	$2.70	-$5.89K	Mar 01, 2024	294.64K	Tax	—	Feb 29	View
From 4	-0.01	2.18K	$1.92	-$4.19K	Feb 01, 2024	296.82K	Tax	—	Jan 31	View
From 4	-0.01	1.79K	$2.46	-$4.41K	Jan 03, 2024	299.00K	Tax	—	Dec 31	View
From 4	-0.01	1.79K	$1.77	-$3.17K	Dec 01, 2023	300.79K	Tax	—	Nov 30	View
From 4	-0.01	1.79K	$1.47	-$2.63K	Nov 01, 2023	302.58K	Tax	—	Oct 31	View
From 4	-0.01	1.79K	$1.70	-$3.04K	Oct 02, 2023	304.37K	Tax	—	Sep 30	View
From 4	-0.01	1.79K	$2.51	-$4.50K	Sep 01, 2023	306.16K	Tax	—	Aug 31	View
From 4	-0.01	1.79K	$2.99	-$5.36K	Aug 01, 2023	307.95K	Tax	—	Jul 31	View
From 4	-0.01	1.79K	$3.00	-$5.37K	Jul 03, 2023	309.74K	Tax	—	Jun 30	View
From 4	—	55.90K	—	—	Jun 15, 2023	55.90K	Grant	—	Jun 14	View
From 4	-0.01	1.79K	$3.15	-$5.64K	Jun 01, 2023	311.54K	Tax	—	May 31	View
From 4	-0.01	1.79K	$3.37	-$6.04K	May 02, 2023	313.33K	Tax	—	Apr 30	View
From 4	-0.01	1.79K	$2.68	-$4.80K	Apr 03, 2023	315.12K	Tax	—	Mar 31	View
From 4	1.09	348.21K	$2.98	-$5.34K	Mar 01, 2023	666.91K	Grant	—	Feb 10 - 28	View
From 4	-0.01	2.18K	$3.79	-$8.27K	Feb 02, 2023	318.70K	Tax	—	Jan 31	View
From 4	-0.01	1.79K	$8.25	-$14.78K	Jan 03, 2023	320.88K	Tax	—	Dec 31	View
From 4	-0.01	1.79K	$11.01	-$19.72K	Dec 01, 2022	322.67K	Tax	—	Nov 30	View
From 4	-0.01	1.79K	$6.89	-$12.34K	Nov 01, 2022	324.46K	Tax	—	Oct 31	View
From 4	-0.01	1.79K	$7.70	-$13.79K	Oct 04, 2022	326.25K	Tax	—	Sep 30	View
From 4	-0.01	1.79K	$8.71	-$15.60K	Sep 01, 2022	328.04K	Tax	—	Aug 31	View
From 4	-0.01	1.79K	$3.40	-$6.09K	Aug 01, 2022	329.84K	Tax	—	Jul 31	View
From 4	-0.01	1.79K	$2.85	-$5.10K	Jul 01, 2022	331.63K	Tax	—	Jun 30	View
From 4	-0.01	1.79K	$2.41	-$4.32K	Jun 03, 2022	333.42K	Tax	—	May 31	View
From 4	-0.01	1.79K	$3.48	-$6.23K	May 06, 2022	335.21K	Tax	—	Apr 30	View
From 4	-0.01	1.79K	$5.00	-$8.95K	Apr 04, 2022	337.00K	Tax	—	Mar 31	View
From 4	-0.01	1.79K	$6.48	-$11.61K	Mar 04, 2022	338.79K	Tax	—	Feb 28	View
From 4	—	200.00K	—	—	Feb 24, 2022	200.00K	Grant	—	Feb 22	View
From 4	-0.01	2.18K	$9.56	-$20.85K	Feb 02, 2022	340.58K	Tax	—	Jan 31	View
From 4	-0.01	2.89K	$19.63	-$56.81K	Jan 05, 2022	342.76K	Tax	—	Dec 31	View
From 4	-0.01	4.09K	$22.27	-$91.10K	Dec 07, 2021	345.66K	Sale	—	Nov 30 - 02	View
From 4	-0.00	399.00	$23.89	-$9.53K	Dec 06, 2021	349.75K	Sale	—	Nov 29	View
From 4	-0.00	1.58K	$25.26	-$39.92K	Nov 30, 2021	350.15K	Sale	—	Nov 22 - 24	View
From 4	-0.01	2.99K	$30.18	-$90.35K	Oct 07, 2021	351.73K	Sale	—	Oct 01	View
From 4	-0.09	33.24K	$40.16	-$1.33M	Aug 30, 2021	354.72K	Sale	—	Aug 26	View
From 4	0.10	34.96K	—	—	Jun 16, 2021	387.96K	Acquisition	—	Jun 14	View
From 4	—	154.94K	—	—	Dec 17, 2020	154.94K	Grant	—	Dec 15	View
From 3	—	—	—	—	Dec 15, 2020	353.00K	—	—	—	View

apexigen, inc.

Updated: Aug 25, 2023

Form Type	Δ Own, %	Traded Shares	Price	Size, $	Filing Date	Own, %	Type	Scheduled	Trade Dates	SEC Filing
From 4	-1.00	134.08K	—	—	Aug 25, 2023	—	Disposition	—	Aug 23	View
From 4	—	100.00K	—	—	Oct 03, 2022	100.00K	Grant	—	Sep 29	View
From 3	—	—	—	—	Aug 08, 2022	—	—	—	—	View

spring bank pharmaceuticals, inc.

Updated: Jun 25, 2020

Form Type	Δ Own, %	Traded Shares	Price	Size, $	Filing Date	Own, %	Type	Scheduled	Trade Dates	SEC Filing
From 4	—	7.50K	—	—	Jun 25, 2020	7.50K	Grant	—	Jun 24	View
From 4	0.50	12.50K	—	—	Jan 02, 2020	37.48K	Grant	—	Dec 31	View
From 4	0.30	5.74K	—	—	Oct 01, 2019	24.98K	Grant	—	Sep 30	View
From 4	—	7.50K	—	—	Jul 11, 2019	7.50K	Grant	—	Jul 10	View
From 4	0.39	5.35K	—	—	Jul 01, 2019	19.24K	Grant	—	Jun 28	View
From 4	6.37	12.00K	$4.09	$49.08K	Jun 28, 2019	13.88K	Purchase	—	Jun 28	View
From 4	—	1.88K	—	—	Apr 02, 2019	1.88K	Grant	—	Mar 29	View
From 4	—	11.00K	—	—	Aug 17, 2018	11.00K	Grant	—	Aug 15	View
From 3	—	—	—	—	Aug 17, 2018	—	—	—	—	View

celgene corp /de/

See Remarks Officer

Updated: Feb 20, 2018

Form Type	Δ Own, %	Traded Shares	Price	Size, $	Filing Date	Own, %	Type	Scheduled	Trade Dates	SEC Filing
From 4	-0.05	2.33K	$95.26	-$221.86K	Feb 20, 2018	52.21K	Options	—	Feb 17	View
From 4	—	7.28K	—	—	Feb 15, 2018	7.28K	Grant	—	Feb 13	View
From 4	—	14.10K	—	—	Jan 31, 2018	14.10K	Grant	—	Jan 29	View
From 4	-0.04	1.77K	$107.06	-$189.28K	Dec 20, 2017	47.25K	Options	—	Dec 19	View
From 4	—	36.44K	—	—	Oct 31, 2017	36.44K	Grant	—	Oct 30	View
From 4	0.25	11.50K	$134.10	-$347.59K	Aug 01, 2017	59.71K	Options	—	Jul 28 - 31	View
From 3/A	—	—	—	—	Aug 01, 2017	6.18K	—	—	—	View
From 4	—	21.22K	—	—	May 02, 2017	21.22K	Grant	—	May 01	View
From 4	—	12.98K	—	—	Jan 31, 2017	12.98K	Grant	—	Jan 30	View
From 4	-0.08	3.32K	$118.93	-$394.61K	Dec 27, 2016	39.20K	Options	—	Dec 23	View
From 4	-0.05	1.94K	$117.63	-$228.67K	Dec 06, 2016	36.11K	Options	—	Dec 02	View
From 4	—	35.59K	—	—	Nov 02, 2016	35.59K	Grant	—	Oct 31	View
From 4	—	12.98K	—	—	Aug 01, 2016	12.98K	Grant	—	Aug 01	View
From 4	0.40	14.82K	$103.41	-$515.71K	May 03, 2016	54.12K	Options	—	Apr 29 - 02	View
From 4	—	8.63K	—	—	Feb 02, 2016	8.63K	Grant	—	Feb 01	View
From 4	0.16	5.44K	$112.17	-$290.74K	Dec 18, 2015	42.20K	Options	—	Dec 16 - 17	View
From 4	-0.13	5.18K	$106.55	-$552.46K	Dec 07, 2015	36.75K	Options	—	Dec 03	View
From 4	—	8.63K	—	—	Nov 10, 2015	8.63K	Grant	—	Nov 09	View
From 4	—	8.63K	—	—	Jul 29, 2015	8.63K	Grant	—	Jul 27	View
From 4	0.40	9.05K	$108.06	-$332.50K	May 04, 2015	34.06K	Options	—	Apr 30 - 04	View
From 4	—	5.00K	—	—	Feb 04, 2015	5.00K	Grant	—	Feb 02	View
From 4	—	15.17K	—	—	Dec 23, 2014	15.17K	Grant	—	Dec 19	View
From 4	-0.52	3.46K	$113.69	-$393.14K	Dec 02, 2014	5.54K	Options	—	Nov 30	View
From 4	—	5.00K	—	—	Oct 29, 2014	5.00K	Grant	—	Oct 27	View
From 3	—	—	—	—	Aug 05, 2014	—	—	—	—	View
From 3	—	—	—	—	Aug 05, 2014	2.33K	—	—	—	View

TTNPtitan pharmaceuticals inc

Updated: Sep 19, 2017VIEW QUOTE

Form Type	Δ Own, %	Traded Shares	Price	Size, $	Filing Date	Own, %	Type	Scheduled	Trade Dates	SEC Filing
From 4	—	10.00K	—	—	Sep 19, 2017	10.00K	Grant	—	Sep 15	View
From 3	—	—	—	—	Jan 06, 2017	—	—	—	—	View

Benzinga

Benzinga

Net Worth & Trading Activity Over Time

Monthly Trading Pattern

Past Insider Trading and Trends

Holdings & Transactions